281
Views
1
CrossRef citations to date
0
Altmetric
Review

Algorithm for the management of asthma in pregnant women: a protocol to optimize processes in healthcare

, &
Pages 1003-1012 | Received 28 Jul 2017, Accepted 09 Oct 2017, Published online: 23 Oct 2017

References

  • Plaza Moral V, Alonso Mostaza S, Alvarez Rodríguez C, et al. Spanish guideline on the management of asthma. J Investig Allergol Clin Immunol. 2016;26(Suppl 1):1–92.
  • British Thoracic Society, Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma. 2016. [Internet]. [cited 2017 Oct 1]. Available from: https://www.brit-thoracic.org.uk/document-library/clinical-information/asthma/btssign-asthma-guideline-2016/
  • Kelly W, Massoumi A, Lazarus A. Asthma in pregnancy: physiology, diagnosis, and management. Postgrad Med. 2015;127:349–358.
  • Namazy JA, Chambers C, Schatz M. Safety of therapeutic options for treating asthma in pregnancy. Expert Opin Drug Saf. 2014;13:1613–1621.
  • Charlton RA, Hutchison A, Davis KJ, et al. Asthma management in pregnancy. PloS One. 2013;8:e60247.
  • 2017 GINA report: global strategy for asthma management and prevention [Internet]. Glob. Initiat. Asthma - GINA. [cited 2017 Oct 1]. Available from: http://ginasthma.org/2017-gina-report-global-strategy-for-asthma-management-and-prevention/
  • Schatz M, Harden K, Forsythe A, et al. The course of asthma during pregnancy, post partum, and with successive pregnancies: a prospective analysis. J Allergy Clin Immunol. 1988;81:509–517.
  • Lim AS, Stewart K, Abramson MJ, et al. Asthma during pregnancy: the experiences, concerns and views of pregnant women with asthma. J Asthma. 2012;49:474–479.
  • Zairina E, Stewart K, Abramson MJ, et al. The effectiveness of non-pharmacological healthcare interventions for asthma management during pregnancy: a systematic review. BMC Pulm Med. 2014;14:46.
  • Hansen C, Joski P, Freiman H, et al. Medication exposure in pregnancy risk evaluation program: the prevalence of asthma medication use during pregnancy. Matern Child Health J. 2013;17:1611–1621.
  • Jølving LR, Nielsen J, Kesmodel US, et al. Prevalence of maternal chronic diseases during pregnancy – a nationwide population based study from 1989 to 2013. Acta Obstet Gynecol Scand. 2016;95:1295–1304.
  • Mattes J, Murphy VE, Powell H, et al. Prenatal origins of bronchiolitis: protective effect of optimised asthma management during pregnancy. Thorax. 2014;69:383–384.
  • Wu PY, Udani V, Chan L, et al. Colloid osmotic pressure: variations in normal pregnancy. J Perinat Med. 1983;11:193–199.
  • Murphy VE, Powell H, Wark PAB, et al. A prospective study of respiratory viral infection in pregnant women with and without asthma. Chest. 2013;144:420–427.
  • Ali Z, Hansen AV, Ulrik CS. Exacerbations of asthma during pregnancy: impact on pregnancy complications and outcome. J Obstet Gynaecol. 2015;36:1–7.
  • Trønnes H, Wilcox AJ, Markestad T, et al. Associations of maternal atopic diseases with adverse pregnancy outcomes: a national cohort study. Paediatr Perinat Epidemiol. 2014;28:489–497.
  • Rejnö G, Lundholm C, Gong T, et al. Asthma during pregnancy in a population-based study - pregnancy complications and adverse perinatal outcomes. Laine K, Editor. PLoS ONE. 2014;9:e104755.
  • Blais L, Kettani F-Z FA. Associations of maternal asthma severity and control with pregnancy complications. J Asthma. 2014;51:391–398.
  • Baribeau V, Beauchesne MF, Rey E, et al. The use of antiasthmatic medications during pregnancy and the risk of gestational diabetes. Pharmacoepidemiol Drug Saf. 2015;24:266–267.
  • Gregersen TLUC. Safety of bronchodilators and corticosteroids for asthma during pregnancy: what we know and what we need to do better. J Asthma Allergy. 2013;6:117–125.
  • Juniper EF, Newhouse MT. Effect of pregnancy on asthma: systematic review and meta-analysis. In: Schatz M, Zeiger RS, Claman HN, editors. Asthma and immunological diseases in pregnancy and early infancy. New York: Marcel Dekker; 1993. p. 223–250.
  • Powell H, Murphy VE, Hensley MJ, et al. Rhinitis in pregnant women with asthma is associated with poorer asthma control and quality of life. J Asthma. 2015;52:1023–1030.
  • Tamási L, Horváth I, Bohács A, et al. Asthma in pregnancy–immunological changes and clinical management. Respir Med. 2011;105:159–164.
  • Toldi G, Molvarec A, Stenczer B, et al. Peripheral T(h)1/T(h)2/T(h)17/regulatory T-cell balance in asthmatic pregnancy. Int Immunol. 2011;23:669–677.
  • Murphy VE, Gibson PG, Giles WB, et al. Maternal asthma is associated with reduced female fetal growth. Am J Respir Crit Care Med. 2003;168:1317–1323.
  • Dombrowski MP, Schatz M, Wise R, et al. Asthma during pregnancy. Obstet Gynecol. 2004;103:5–12.
  • Tamási L, Bohács A, Pállinger E, et al. Increased interferon-gamma- and interleukin-4-synthesizing subsets of circulating T lymphocytes in pregnant asthmatics. Clin Exp Allergy. 2005;35:1197–1203.
  • Namazy JA, Murphy VE, Powell H, et al. Effects of asthma severity, exacerbations and oral corticosteroids on perinatal outcomes. Eur Respir J. 2013;41:1082–1090.
  • Tegethoff M, Olsen J, Schaffner E, et al. Asthma during pregnancy and clinical outcomes in offspring: a national cohort study. Pediatrics. 2013;132:483–491.
  • Liu X, Agerbo E, Schlünssen V, et al. Maternal asthma severity and control during pregnancy and risk of offspring asthma. J Allergy Clin Immunol. 2017;S0091-6749(17)30854-0. [Epub ahead of print].
  • Beau A-B, Didier A, Hurault-Delarue C, et al. Prescription of asthma medications before and during pregnancy in France: an observational drug study using the EFEMERIS database. J Asthma. 2017;54:258–264.
  • Stenius-Aarniala BS, Hedman J, Teramo KA. Acute asthma during pregnancy. Thorax. 1996;51:411–414.
  • Powell H, McCaffery K, Murphy VE, et al. Psychosocial outcomes are related to asthma control and quality of life in pregnant women with asthma. J Asthma. 2011;48:1032–1040.
  • Hasegawa K, Cydulka RK, Sullivan AF, et al. Improved management of acute asthma among pregnant women presenting to the ED. Chest. 2015;147:406–414.
  • Measuring fractional exhaled nitric oxide concentration in asthma: NIOX MINO, NIOX VERO and NObreath | Guidance and guidelines | NICE [Internet]. [cited 2017 Oct 1]. Available from: https://www.nice.org.uk/guidance/dg12
  • Powell H, Murphy VE, Taylor DR, et al. Management of asthma in pregnancy guided by measurement of fraction of exhaled nitric oxide: a double-blind, randomised controlled trial. The Lancet. 2011;378:983–990.
  • Murphy VE, Jensen ME, Mattes J, et al. The breathing for life trial: a randomised controlled trial of fractional exhaled nitric oxide (FENO)-based management of asthma during pregnancy and its impact on perinatal outcomes and infant and childhood respiratory health. BMC Pregnancy Childbirth. 2016;16:111.
  • Monteiro de Aguiar M, Jâ R, de Melo Junior EF, et al. Validation of the asthma control test in pregnant asthmatic women. Respir Med. 2014;108:1589–1593.
  • Juniper EF, Bousquet J, Abetz L, et al. Identifying “well-controlled” and “not well-controlled” asthma using the Asthma Control Questionnaire. Respir Med. 2006;100:616–621.
  • Schatz M, Dombrowski MP, Wise R, et al. The relationship of asthma medication use to perinatal outcomes. J Allergy Clin Immunol. 2004;113:1040–1045.
  • Tata LJ, Lewis SA, McKeever TM, et al. Effect of maternal asthma, exacerbations and asthma medication use on congenital malformations in offspring: a UK population-based study. Thorax. 2008;63:981–987.
  • Lim A, Stewart K, König K, et al. Systematic review of the safety of regular preventive asthma medications during pregnancy. Ann Pharmacother. 2011;45:931–945.
  • Murphy VE, Jensen ME, Gibson PG. Asthma during pregnancy: exacerbations, management, and health outcomes for mother and infant. Semin Respir Crit Care Med. 2017;38:160–173.
  • National Heart, Lung, and Blood Institute WW, National Asthma Education and Prevention Program Asthma and Pregnancy Working Group. Managing asthma during pregnancy: recommendations for pharmacologic treatment-2004 update. J Allergy Clin Immunol. 2005;115:34–46. NAEPP expert panel report.
  • Källén B, Rydhstroem H, Aberg A. Congenital malformations after the use of inhaled budesonide in early pregnancy. Obstet Gynecol. 1999;93:392–395.
  • Norjavaara E, de Verdier MG. Normal pregnancy outcomes in a population-based study including 2968 pregnant women exposed to budesonide. J Allergy Clin Immunol. 2003;111:736–742.
  • de Aguiar MM, Da Silva HJ, Rizzo J, et al. Inhaled beclomethasone in pregnant asthmatic women - a systematic review. Allergol Immunopathol (Madr). 2014;42:493–499.
  • Charlton RA, Snowball JM, Nightingale AL, et al. Safety of fluticasone propionate prescribed for asthma during pregnancy: a UK population-based cohort study. J Allergy Clin Immunol Pract. 2015;3:772–9.e3.
  • Cossette B, Beauchesne M-F, Forget A, et al. Relative perinatal safety of salmeterol vs formoterol and fluticasone vs budesonide use during pregnancy. Ann Allergy Asthma Immunol. 2014;112:459–464.
  • Eltonsy S, Kettani F-Z BL. Beta2-agonists use during pregnancy and perinatal outcomes: a systematic review. Respir Med. 2014;108:9–33.
  • Dombrowski MP, Schatz M, Wise R, et al. Randomized trial of inhaled beclomethasone dipropionate versus theophylline for moderate asthma during pregnancy. Am J Obstet Gynecol. 2004;190:737–744.
  • Byrjalsen A, Frøslev T, Telén Andersen AB, et al. Use of corticosteroids during pregnancy and risk of asthma in offspring: a nationwide Danish cohort study. BMJ Open. 2014;4:e005053.
  • Namazy J, Cabana MD, Scheuerle AE, et al. The Xolair Pregnancy Registry (EXPECT): the safety of omalizumab use during pregnancy. J Allergy Clin Immunol. 2015;135:407–412.
  • Lim AS, Stewart K, Abramson MJ, et al. Multidisciplinary approach to management of maternal asthma (MAMMA): a randomized controlled trial. Chest. 2014;145:1046–1054.
  • Grzeskowiak LE, Smith B, Roy A, et al. An observational study of the impact of an antenatal asthma management service on asthma control during pregnancy. Eur J Obstet Gynecol Reprod Biol. 2016;197:48–53.
  • Ali Z, Nilas L, Ulrik CS. Low risk of adverse obstetrical and perinatal outcome in pregnancies complicated by asthma: a case control study. Respir Med. 2016;120:124–130.
  • Baarnes CB, Hansen AV, Ulrik CS. Enrolment in an asthma management program during pregnancy and adherence with inhaled corticosteroids: the ‘management of asthma during pregnancy” program’. Respiration. 2016;92:9–15.
  • Murphy VE, Gibson PG, Talbot PI, et al. Asthma self-management skills and the use of asthma education during pregnancy. Eur Respir J. 2005;26:435–441.
  • Bain E, Pierides KL, Clifton VL, et al. Interventions for managing asthma in pregnancy. Cochrane Database Syst Rev. 2014;10:CD010660.
  • Burgess L, McCaffery K, Powell H, et al. The influence of asthma control on psychosocial outcomes for pregnant women with asthma. J Asthma. 2015;52:1013–1019.
  • Murphy VE, Gibson P, Talbot PI, et al. Severe asthma exacerbations during pregnancy. Obstet Gynaecol. 2005;106:1046–1054.
  • Ali Z, Nilas L, Ulrik CS. Excessive gestational weight gain in first trimester is a risk factor for exacerbation of asthma during pregnancy: a prospective study of 1283 pregnancies. J Allergy Clin Immunol. 2017. [Epub ahead of print].
  • Pollart SM, Compton RM, Elward KS. Management of acute asthma exacerbations. Am Fam Physician. 2011;84:40–47.
  • Powell H, McCaffery K, Murphy VE, et al. Psychosocial variables are related to future exacerbation risk and perinatal outcomes in pregnant women with asthma. J Asthma. 2013;50:383–389.
  • Koo S-M, Kim Y, Park C, et al. Effect of pregnancy on quantitative medication use and relation to exacerbations in asthma. BioMed Res Int. 2017;2017:8276190.
  • Murphy VE, Clifton VL, Gibson PG. The effect of cigarette smoking on asthma control during exacerbations in pregnant women. Thorax. 2010;65:739–744.
  • Prednisolone ODT - FDA prescribing information, side effects and uses [Internet]. Drugs.com. [cited 2017 Oct 17]. Available from: https://www.drugs.com/pro/prednisolone-odt.html
  • National Asthma Council Australia. Australian asthma handbook, version 1.2. Special considerations for asthma management in women who are contemplating pregnancy, pregnant or breastfeeding [Internet]. [cited 2017 Oct 1]. Available from: http://www.asthmahandbook.org.au
  • Amir LH, Pirotta MV, Raval M. Breastfeeding–evidence based guidelines for the use of medicines. Aust Fam Physician. 2011;40:684–690.
  • Sammaritano LR, Bermas BL. Rheumatoid arthritis medications and lactation. Curr Opin Rheumatol. 2014;26:354–360.
  • Etwel F, Faught LH, Rieder MJ, et al. The risk of adverse pregnancy outcome after first trimester exposure to H1 antihistamines: a systematic review and meta-analysis. Drug Saf. 2017;40:121–132.
  • Plaza V, López-Viña A, Cosio BG, et al. Test of adherence to inhalers. Arch Bronconeumol. 2017;53:360–361.
  • Vaccines and Medications in Pregnancy Surveillance System | AAAAI [Internet].[cited 2017 Mar 5]. Available from: http://www.aaaai.org/about-aaaai/strategic-relationships/vampss
  • Nixon J, Newbold P, Mustelin T, et al. Monoclonal antibody therapy for the treatment of asthma and chronic obstructive pulmonary disease with eosinophilic inflammation. Pharmacol Ther. 2016;169:57–77.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.